Augmenta Bioworks, Inc.

Augmenta Biosciences, Inc.

Payam Shahi

Christopher J Emig

Marco Antonio Mena

Steven C Henry

John Beaber

John Haliburton

Rosanna Man Wah Chau

Kim-Xuan Nguyen

YuShuan Lai

The disclosure relates generally to the field of immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. The disclosure also relates to anti-SARS-CoV-2 antibodies that have been obtained from subjects who became immune to this coronavirus, and to methods of using these anti-SARS-CoV-2 antibodies. Methods for neutralizing SARS-CoV-2 are disclosed, as well treatments for SARS-COV-2 using the anti-SARS-CoV-2 antibodies.

Antibodies for SARS-CoV-2 and uses thereof

Described herein are immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. Also described herein are nucleic acids encoding the immune binding proteins in which the natural multimeric association of chains is maintained in the nucleic acids and the immune binding proteins made therefrom. For example, nucleic acids encoding antibodies that are amplified from a B-cell using the methods described herein maintain the natural pairing of heavy and light chains from the B-cell. This maintenance of pairing (or multimerization) produces libraries and/or repertoires of immune binding proteins that are enriched for useful binding molecules.

Methods for isolating immune binding proteins

Growing community of inventors

Santa Clara, CA, United States of America

Payam Shahi